Given the close relationship between AMPK and SIRT1 activation and their effects on obesity and its-associated inflammation, AMPK/SIRT1 activity could be a target for prevention or treatment of obesity-associated endocrine and metabolic effects. Here, SIRT1 is linked to obesity due to melanocortin 4 receptor deficiency.